SOCS1 and neoplasm: Silencing of SOCS1 allowed IL-6 to induce CD155 overexpression; thus, constitutive expression of SOCS1 in tumor cells prevented CD155 overexpression upon IL-6 stimulation and may account for the weak correlation found in tumors.